Search for content, post, videos

Ultimovacs implements operational adjustments, including reducing its workforce

Carlos de Sousa
Ultimovacs has announced a plan to optimize its business operations to support the continuous advancement of UV1 and long-term business growth. “We remain dedicated to our investigation of the potential impact of UV1 vaccine across several cancer indications and immunotherapy combinations, and
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.